WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 1552

Legislative bill overview

HB 1552 is an Indiana bill currently in the Insurance Committee that addresses health insurance coverage requirements for chronic disease treatments. The bill was introduced on January 21, 2025, by Representatives Andrade, Pfaff, and Gore. Specific coverage mandates and disease categories have not been publicly detailed at this early stage of the legislative process.

Why is this important

Chronic disease treatment coverage directly affects healthcare affordability for Hoosiers managing conditions like diabetes, heart disease, and asthma. Insurance coverage mandates can influence premium costs, insurer participation in the market, and patient access to medications and therapies. The outcome could shape how healthcare costs are distributed between patients, insurers, and employers across Indiana.

Potential points of contention

  • Mandate cost concerns: Insurers may argue that expanded coverage requirements increase premiums for all policyholders, while patient advocates contend coverage gaps create financial hardship for those with chronic conditions
  • Scope definition: Disagreement may emerge over which treatments, medications, and conditions qualify as necessary chronic disease care versus optional or experimental therapies
  • Insurance market impact: Stricter mandates could affect which insurers offer plans in Indiana or how competitively they price policies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.